Category Archives: deCODEme

The Gift of Knowledge - Prevention Starts with Knowing the Odds

Posted by admin under Breast Bancer, Customer Stories, Genetic Tests, deCODEme on Dec 24
Prevention Starts with Knowing the Odds. That's the opinion of 27 year old Canadian grad student who is especially concerned about Breast Cancer and she has her reasons. She decided to learn how to use the GAIL model to calculate her risk.

deCODEme customer Anna Peterson on top of Acropolis on a camping trip in Athens.

By: Anna Peterson
I am a fit, healthy, 27 year old Canadian graduate student looking forward to the future. So why, you might wonder, did I decide to take the deCODEme genetic test? It’s simple really. Information is the key to prevention. By learning about my genetic predisposition for different illnesses, I will be better prepared to take an active role in my future health care decisions.
Many of my friends were surprised that I decided to take this comprehensive genetic test. Some were curious about the story my genes would tell, while others wondered whether or not I really wanted to know. When I put my genetic sample in the mail, I felt a little nervous about the chain of events I had set in motion, but curiosity overcame fear. In my opinion, knowledge is power and I’d rather make lifestyle changes in my 20s than in my 60s.

Read More »

No responses yet   |   Bookmark and Share   |   Tags: , , , , .

Genetic test as a Christmas present

Posted by admin under Breast Bancer, Customer Stories, Genetic Tests, deCODE genetics, deCODEme on Nov 21
Pam Bale is going to get her three grown-up children a deCODEme genetic test for Christmas

Pam Bale is going to get her three grown-up children a deCODEme genetic test for Christmas

Pam Bale knows what she wants to get her three children for Christmas. Two of Pam’s children are in their 20s and the other is 30. In other words, a little too old for video games. So they’re not getting a Wii or Guitar Hero. Instead, Pam wants to surprise her kids on December 25th with a genetic test.

“I think the kit would open up all sorts of doors to their future,” says Pam. “They are young adults, and at their ages the test can show them what medical concerns they might face down the road. They are young enough so they can take the steps to avoid those concerns. It would make their whole future happier and healthier and extend their lives. I think it’s a great gift to give to my kids. So don’t tell them. I don’t want to ruin the surprise.”

For the whole interview with Pam Bale go to deCODEme Customer Stories.

No responses yet   |   Bookmark and Share   |   Tags: , , , .

Pam sees DNA test as a gift

Posted by Martin Regal under Customer Stories, Genetic Tests, deCODE genetics, deCODEme on Nov 4
genetic test customer Pamela Ayers and her grand-children, Spokane, WA

Genetic test customer Pamela Ayers and her grand-children, Spokane, WA

After watching her parents and brother suffer with diseases that might have been prevented with the right care, Pam Ayers has become vehemently proactive. She now believes that genetic health scans are the way of the future and early testing could help parents change their own and their children’s life-style for the better. This proud grandmother is taking care of her family.

Read the whole interview with Pamela Ayers in the Customer Stories section of deCODEme.

No responses yet   |   Bookmark and Share   |   Tags: , , , .

Time magazine’s Best Inventions of 2008: The Retail DNA Test

Posted by admin under Genetic Tests, deCODE genetics, deCODEme on Nov 2
Time magazine's Best Inventions of 2008: The Retail DNA Test

Time magazine's Best Inventions of 2008: The Retail DNA Test

deCODE staffers were buzzing about Time magazine’s announcement this week of its best invention of 2008: the retail DNA test. As the creators of deCODEme, the first personal genome scan on the market, deCODE staff members were not about to quibble about the date (deCODEme was actually launched on November 16, 2007).

Indeed, the value of deCODE’s capabilities and service is perhaps best demonstrated by the launch of web portals offering similar services based largely upon deCODE’s discoveries, and Time’s article underscored the potential of this new field by devoting considerable attention to the high-powered tech luminaries who have come chasing deCODEme’s tail.

But what sets deCODE apart from the pack is not that it was the first personal genome analysis service to hit the market, but that it grew out of the biggest and to date most successful effort to discover the genetic factors that increase individual risk of public health challenges like from heart attack and breast cancer. More than a dozen years of large-scale research in human genetics, with the experience of having analyzed the genomes of hundreds of thousands of people, really does count.

The competition clearly feels the weight of deCODE’s advantage, which Time highlighted last year when it named CEO Kari Stefansson to the Time 100 list for the company’s pioneering work in genetics. As Time quotes the founder of a deCODEme competitor: “We could make great discoveries if we just had more information.” Perhaps, but fortunately with deCODEme the public doesn’t have to wait for the dot-commers to bone up on their genetics.

Congratulations again to the deCODEme team!

5 responses   |   Bookmark and Share   |   Tags: , , , , .

deCODEme customer support has your answers

Posted by admin under Genetic Tests, deCODE diagnostics, deCODE genetics, deCODEme on Oct 31
deCODE Customer Rep Larus Jon Gudmundsson and Genetic Councelor Kristleifur Kristinsson

deCODE customer rep Larus Jon Gudmundsson and genetic counselor Kris Kristjansson MD

Tapping the vast resources of deCODEme scientists

The users of deCODEme show great interest in their results and are not afraid to ask questions. deCODEme customer support welcomes all questions and inquiries and taps the vast knowledge base and resources of its research teams to respond to all emails as comprehensively and quickly as possible. Among the more general questions we receive is the following.

Question
“I’m seriously thinking about doing the DNA test. Now I only have to decide from which company. How does your test compare with tests from other companies?”
Read More »

1 response   |   Bookmark and Share   |   Tags: , , , , , .

The battle against breast cancer gets personalized

Posted by Edward Weinman under Breast Bancer, Genetic Research, Genetic Tests, deCODEme on Oct 27
deCODE Breast Cancer enables women to understand whether they may benefit from more intensive screening, monitoring or preventive drug therapy.

A new genetic test assessing a woman's risk of developing the most common forms of breast cancer has arrived. Can the test, developed by the biopharmaceutical company deCODE, improve the way doctors screen for breast cancer?

Breast cancer kills 40,000 people a year in the U.S. This is about the population of Atlantic City, New Jersey. Imagine, each year an entire city wiped out by breast cancer.

To help fight breast cancer, a new test assessing individual risk has just become available. For women without a clear family history of the disease, the deCODE BreastCancerTM test assesses their personal risk of developing the most common forms of breast cancer. The DNA test, launched by the biopharmaceutical company deCODE, makes it possible to identify those women at significantly higher than average risk, helping doctors use new screening technologies and treatments in a more targeted, personalized and effective manner.

Read More »

No responses yet   |   Bookmark and Share   |   Tags: , , , .

Heart attack and stroke prevention: measuring lifetime risk

Posted by Martin Regal under Customer Stories, Genetic Tests, deCODE diagnostics, deCODE genetics, deCODEme on Oct 20
Amy Doneen, Director of the Heart Attack & Stroke Prevention Center, Spokane, WA.

Amy Doneen, Director of the Heart Attack & Stroke Prevention Center, Spokane, WA.

Amy Doneen at the Heart Attack and Stroke Prevention Clinic in Spokane, Washington, talks about an “exciting new time” for preventive health care. Amy, a nurse practitioner, has been using nutrigenomics (the response of genes to nutrition) as part of the program for more than a decade and with outstanding results. “The goal,” says Amy “is to find out what path a patient is on to developing certain diseases and kick them off that path.” Scanning for risk factor for common conditions (such as diabetes, heart attack, several types of cancer etc.) She emphasizes the importance of gauging lifetime risk as against clinical tests that usually concentrate on immediate high risk. According to Amy, some people walk away from the second kind with a negative result and think things are always going to be fine. Genetic testing is just arriving to the market place, but Americans currently spending nearly $50 billion on stroke care alone, the time is ripe to back all advances in preventive medicine.

To read more and watch parts of the interview with Amy Doneen visit the deCODEme Customer Stories.

No responses yet   |   Bookmark and Share   |   Tags: , , , , .

The Breast Cancer Network of Strength celebrates 30 years of invaluable support

Posted by Martin Regal under Genetic Research, News, deCODE diagnostics, deCODEme on Oct 16
Breast Cancer Network of Strength was started by Mimi Kaplan and Ann Marcou

Breast Cancer Network of Strength was started by Mimi Kaplan and Ann Marcou.

Attitudes towards breast cancer have changed quite a lot over the past three decades, a fact evidenced by the outpouring of response when stars such as Olivia Newton-John, Kylie Minogue, and, most recently, Christina Applegate, went public with their personal struggles with the disease. But this change in attitude is also reflected in many other ways and not least in the adoption of a new name for the patient advocacy and support organization that until now called itself Y-ME? Tomorrow, a gala event held at the Fairmont Hotel in Chicago will celebrate Breast Cancer Awareness Month and the evolution of Y-ME, 30 years on, into the Breast Cancer Network of Strength-a change they hope that will better communicate the organization’s mission to promote a proactive, engaged and positive approach to fighting breast cancer.

Read More »

No responses yet   |   Bookmark and Share   |   Tags: , , , , , , .

Genetic test will narrow in on predicting baldness

Posted by Martin Regal under Customer Stories, Genetic Tests, News, deCODE genetics, deCODEme on Oct 14
deCODEme genetic test includes an identification of the male pattern baldness trait.

deCODEme genetic test includes an identification of the male pattern baldness trait.

A team of scientists, led by Professor Tim Spector of King’s College, London, have been taking a closer look at the genetic coordinates for male pattern baldness or androgenic alopecia. Male pattern baldness is the most common form of hair loss in men and one that increases steadily with age. While it has been known for some time that men inherit a tendency for baldness via their x chromosomes from their maternal grandfather, this new research has identified a region on chromosome 20 (20p11) that suggests that a susceptibility for baldness is also inherited directly from one’s father. Read More »

No responses yet   |   Bookmark and Share   |   Tags: , , , , , .

Breast cancer gene tests explained

Posted by Jeff Gulcher under Customer Stories, Genetic Research, Genetic Tests, deCODE diagnostics, deCODE genetics, deCODEme on Oct 12

On October 8th MSNBC published an article by Arthur Caplan, Ph.D. on genetic tests for breast cancer.
The following is a response by Jeff Gulcher, M.D., Ph.D, Chief Scientific Officer at deCODE Genetics.

Arthur Caplan stresses caution in the application of the new genetic risk tests for common diseases and I certainly agree that genetic testing should be applied with care. However, he goes too far when he says that the new deCODE BreastCancer genetic risk test is only useful for women who have two or more close relatives with breast cancer, is not based on large enough studies to be accurate, and is not regulated.

There are two major types of breast cancer: the rare, early onset form that occurs in certain families and for the detection (for which the Myriad Genetic test is well suited), and the common form which accounts for 95 percent of breast cancer. The vast majority of women who develop breast cancer do not have the conventional risk factors of family history, pregnancy history or breast density. Unfortunately, many of these women were likely considered to be of average risk before their cancer was found. Therefore, they were not even offered screening with breast MRI which detects two to three times more cancer at an earlier stage than mammography alone, or preventive measures such as tamoxifen treatment which can cut down cancer rates by 40 to 50%.
Read More »

2 responses   |   Bookmark and Share   |   Tags: , , , , , , .

Genetic test was an investment in myself

Posted by Edward Weinman under Customer Stories, Genetic Tests, deCODE genetics, deCODEme on Oct 3
Jack Doughery says deCODEme genetic test was an investment

Jack Doughery says deCODEme genetic test was an investment

Jack Doughery feels great and wants everyone to know it.

“I almost feel evangelical about my health,” says the 62-year-old businessman from Spokane, Washington. “I’m so excited about what can happen if you do the right things and have the right tools.”

Jack started doing the right things once he began what he calls his journey, which kicked off one day after waking up at three in the morning craving a cigarette.

“When you’re waking up at three in the morning, coughing and spluttering, and the only way to calm down is by smoking a cigarette, you don’t have to be too smart to know this might not be the way to go. It got my attention,” he remembers.

One of Jack’s first stops along his grand trip was at Spokane’s Heart Attack and Stroke Prevention Clinic, run by nurse practitioner Amy Doneen. It was Doneen and Dr. Bradley Bale who put Jack on the path to prevention, helping Jack to reshape his life using diagnostic testing, nutrition and exercise.

Recently, Amy Doneen began using a new test to help alter Jack’s journey—deCODEme, a genetic test that scans a patient’s genome for markers relating to 30 various diseases. The deCODEme genetic test gauges a patient’s average and lifetime risk of developing diseases such as Alzheimer’s, heart attack, prostate cancer, and most recently bladder cancer.

Read More »

3 responses   |   Bookmark and Share   |   Tags: , , , , , .

Your genome, your choice: a buyer’s checklist for genetic tests

Posted by Edward Farmer under Genetic Research, deCODE genetics, deCODEme on Sep 17
Scientists at deCODE genetics' Genetic Service Facility lab in Iceland

Scientists at deCODE genetics Genetic Service Facility lab in Iceland

The number of companies offering genetic tests to the public is large and growing. But there are vast and very real differences in the quality, purpose and price of testing services out there. So how do you tell the difference between them? And how do you decide which to use?

Knowing what you want

First and foremost, you need to think about what sort of information you hope to gain from your genome and how accurate you want the results to be. Are you taking the test only for fun, perhaps hoping to talk about your results on Facebook? Read More »

3 responses   |   Bookmark and Share   |   Tags: , , , , .

deCODE and Radboud University discover common variants in the human genome conferring risk of bladder cancer

Posted by Edward Farmer under Genetic Research, Genetic Tests, deCODE genetics, deCODEme on Sep 14

Urinary bladder cancer is something many people have never heard of. But it is the sixth most common form of cancer in the United States, and its environmental risk factors include exposure to toxic chemicals, including some used in industrial processing as well as cigarette smoke. Genetic factors also play a role and may help to elucidate how bladder cancer starts and develops.

Today, deCODE’s cancer group and colleagues at Radboud University in the Netherlands report the discovery of two single letter variants (commonly referred to as SNPs) in the human genome that confer increased risk of bladder cancer. Both are common, and 20 percent of people of European descent carry two copies of the highest impact SNP, located on chromosome 8q24. That puts them at about 50 percent higher likelihood of developing bladder cancer than people who do not carry the variant.

Read More »

No responses yet   |   Bookmark and Share   |   Tags: , , , , , , .

A hypocondriac meets deCODEme and comes out eating apples

Posted by Edward Weinman under Customer Stories, Genetic Tests, deCODE diagnostics, deCODE genetics, deCODEme on Sep 2

A hypocondriac meets deCODEme and comes out eating apples, by Edward Weinman

By Edward Weinman

With a simple swab from the inside of your cheek, deCODE genetics can scan your DNA, map your markers and assess your risk of developing 29 common diseases. Edward Weinman, self-described hypochondriac, wonders if he should look too closely at his possible future.

Read More »

No responses yet   |   Bookmark and Share   |   Tags: , , , , , , , , , , , .

How much did Boonsri Dickinson learn from her home DNA test?

Posted by Edward Farmer under Genetic Tests, deCODE genetics, deCODEme on Aug 22
Science journalist Boonsri Dickinson

Science journalist Boonsri Dickinson

Discover magazine reporter Boonsri Dickinson recently tried out deCODEme, as well as two other genetic scans offered by California-based websites. She discusses her results, and talks to several people who question whether genetic scans should be available to the public. Dickinson seems to be happy she had the chance to take a look at her genome, and went over her results with deCODE CEO Kari Stefansson. She notes that as “deCODE is known for discovering genetic risk factors…I decided to use deCODEme to validate the other two,” concluding that “deCODE genetics was authoritative.” Her article, ‘Inside Out: A DNA Diary,’ appeared on newsstands in August and can be found on the Discovermagazine.com website.

No responses yet   |   Bookmark and Share   |   Tags: , , , , , .

Genetic tests will drive shift from intervention to prevention says Dr. Kari Stefansson

Posted by Martin Regal under deCODE diagnostics, deCODE genetics, deCODEme on Aug 16

In a recent interview Dr. Kari Stefansson, C.E.O. of deCODE genetics talked about the future for genetic tests such as deCODEme and how he believes that they will drive the shift from intervention to prevention in medicine

No responses yet   |   Bookmark and Share   |   Tags: , , , , .

Welcome to the deCODE blog

Posted by Kari Stefansson under deCODE genetics, deCODEme on Aug 1

As the founder and CEO of deCODE, I want to welcome you to our blog, deCODEyou. This is a place where you can learn not just about deCODE’s discoveries and products but what others are saying about our work and about the application of human genetics to healthcare. We also hope that it will become a place where we can hear from you.

Read More »

1 response   |   Bookmark and Share   |   Tags: , .

BBC - Your DNA’s in the post

Posted by admin under News, deCODE genetics, deCODEme on Jul 29

BBC reporter Rob Liddle writes about the deCODEme genetic test

BBC News Magazine’s Rob Liddle writes about his experience of taking the deCODEme genetic test. Does this new form of diagnosis lead to reduced autonomy or offer greater choice?

Link: See the full article on the BBC News website.

No responses yet   |   Bookmark and Share   |   Tags: , , , .

Genetic test helps to detect prostate cancer

Posted by Jonheidur Isleifsdottir under Customer Stories, News, Prostate Cancer, deCODE genetics, deCODEme on Jul 25

Jeff Gulcher, Chief Scientific Officer of deCODE genetics, creator of the deCODEme test.

Chief scientific officer of deCODE, Jeff Gulcher (48) takes a deCODEme scan that indicates he has a very high risk bracket for prostate cancer. Taking his results to a urologist may have saved his life.

Rick Weiss of the Washington Post reports:

Jeffrey Gulcher had no reason to think much about prostate cancer. He was just 48, and the disease typically strikes later in life. Even the most cautious medical groups agree that most men need not begin annual prostate screenings until age 50.

But Gulcher happens to be the chief scientific officer of deCODE Genetics — one of several companies that, amid some controversy, have begun offering direct-to-consumer DNA tests that can help people predict which diseases they are likely to get. So in April, he spat into a test tube and, without giving the matter much thought, sent the sample in for analysis by his own company.

He was in for a shock.

Read More »

No responses yet   |   Bookmark and Share   |   Tags: , , , , .

deCODE on NBC Nightly News - Part 2

Posted by Berglind Olafsdottir under Genetic Research, News, deCODEme on Jul 23

The second part of NBC Nightly News coverage of deCODE genetics and the genetic research conducted with the help of the Icelandic nation. Bazell continues to look at the company he sees as being at the cutting edge of genetic research.

No responses yet   |   Bookmark and Share   |   Tags: , .